Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia

Journal of the Formosan Medical Association

Volumn 108, Issue 3, 2009, Pages 219-223

  Chen, Chiung Zuei ^a   Fan, Po Sheng ^b   Lin, Chien Chung ^a   Lee, Cheng Hung ^a   Hsiue, Tzuen Ren ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Community acquired pneumonia; Pneumonia severity index; Severity assessment

Indexed keywords

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PREDICTION; PROSPECTIVE STUDY; TERTIARY HEALTH CARE;

EID: 65349193796     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60055-3     Document Type: Article

References (14)

1. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134-41.
2. Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004;125:2140-5.
3. Rello J, Quintana E, Ausina V, et al. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993;103:232-5.
4. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 1998;158:1102-8.
5. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163: 1730-54.
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
7. Jordi R, Maria B, Marta N, et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003;123:147-50.
8. Renaud B, Coma E, Labarere J, et al. Routine use of pneumonia severity index for deciding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 2007;44:41-9.
9. Lim WS, Laing R, Boersma WG. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
10. Lin CC, Lee CH, Chen CZ, et al. Value of the pneumonia severity index in assessment of community-acquired pneumonia. J Formos Med Assoc 2005;104:164-9.
11. Falguera M, Sacristan O, Nogues A, et al. Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity. Arch Intern Med 2001;161: 1866-72.
12. Dean NC, Suchyta MR, Bateman KA, et al. Implementation of admission decision support for community-acquired pneumonia. Chest 2000;117:1368-77.
13. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005;118: 384-92.
14. Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998;279: 1452-7.